Reckitt Benckiser Group (LON:RB) had its price objective lowered by Credit Suisse Group from GBX 5,800 ($75.79) to GBX 5,550 ($72.52) in a report published on Friday, November 1st, Borsen Zeitung reports. Credit Suisse Group currently has an underperform rating on the stock.
A number of other research firms have also recently weighed in on RB. DZ Bank cut their price target on Reckitt Benckiser Group from GBX 6,500 ($84.93) to GBX 6,000 ($78.40) and set a hold rating on the stock in a report on Thursday, October 31st. Berenberg Bank cut their price target on Reckitt Benckiser Group from GBX 7,420 ($96.96) to GBX 7,150 ($93.43) and set a buy rating on the stock in a report on Wednesday, October 23rd. Royal Bank of Canada cut their price target on Reckitt Benckiser Group from GBX 5,900 ($77.09) to GBX 5,300 ($69.25) and set an underperform rating on the stock in a report on Wednesday, October 23rd. Liberum Capital reiterated a buy rating and set a GBX 7,300 ($95.39) price objective on shares of Reckitt Benckiser Group in a research note on Thursday, October 31st. Finally, HSBC set a GBX 7,700 ($100.61) price objective on shares of Reckitt Benckiser Group and gave the company a buy rating in a research note on Thursday, October 10th. Four investment analysts have rated the stock with a sell rating, four have assigned a hold rating and ten have issued a buy rating to the company. The company currently has a consensus rating of Hold and a consensus price target of GBX 6,803.89 ($88.90).
LON RB traded down GBX 49 ($0.64) during trading hours on Friday, reaching GBX 5,910 ($77.22). The company’s stock had a trading volume of 716,737 shares, compared to its average volume of 1,720,000. The company has a current ratio of 0.59, a quick ratio of 0.43 and a debt-to-equity ratio of 85.08. The business has a 50-day simple moving average of GBX 6,094.38 and a 200 day simple moving average of GBX 6,236.48. Reckitt Benckiser Group has a 52 week low of GBX 5,510 ($72.00) and a 52 week high of GBX 6,778 ($88.57). The stock has a market cap of $42.03 billion and a PE ratio of 29.67.
About Reckitt Benckiser Group
Reckitt Benckiser Group plc manufactures, markets, and sells health, hygiene, and home products. The company offers acne treatment creams, facial washes, and cleansing pads; disinfection, hygiene, and first aid products; condoms, sex toys, and lubricants; heartburn and indigestion solutions; and cough and chest congestion, multi-symptom, and sinus remedies for adults and children under the Clearasil, Dettol, Durex, Gaviscon, and Mucinex brands.
See Also: Why do companies engage in swaps?
Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.